Wee Joo Chng

Chng Wee Joo

Appointment(s)
  • Professor, Department of Medicine
  • Senior Consultant, Division of Haematology, Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System
Administrative Appointment(s)
  • Director, National University Cancer Institute, Singapore, National University Health System
  • Head, Division of Haematology, Department of Haematology-Oncology, National University Cancer Institute, National University Health System
  • Deputy Director, Cancer Science Institute of Singapore, National University of Singapore
  • Vice-Dean, Research, NUS Yong Loo Lin School of Medicine
  • Group Director, Research Office, National University Health System
  • Leader, Haematologic Malignancy Tumour Group, National University Cancer Institute, Singapore, National University Health System
  • Lead, Cancer Summit Research Programme, National University Health System
Academic Qualifications
  • PhD, National University of Singapore, Singapore
  • MBChB, University of Leeds, United Kingdom
  • FRCP, Royal College of Edinburgh, United Kingdom | FRCPath, Royal College of Pathologists, United Kingdom
  • FAMS, Academy of Medicine, Singapore
Research Programme(s)
Research Interest(s)
  • Myeloma
  • Genetics
  • Clinical Trials
  • Leukaemia
  • Lymphoma
  • Haematologic Malignancies
Recent Publications
  • 1. de Mel, S., Soon, G. S. -T., Mok, Y., Chung, T. -H., Jeyasekharan, A. D., Chng, W. -J., & Ng, S. -B. (2018). The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation.. Int J Mol Sci, 19(7). doi:10.3390/ijms19071931.
  • 2. Soekojo, C. Y., de Mel, S., Ooi, M., Yan, B., & Chng, W. J. (2018). Potential clinical application of genomics in multiple myeloma. International Journal of Molecular Sciences, 19(6). doi:10.3390/ijms19061721.
  • 3. Shanmugam, M. K., Ahn, K. S., Lee, J. H., Kannaiyan, R., Mustafa, N., Manu, K. A., . . . Kumar, A. P. (2018). Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma. FRONTIERS IN PHARMACOLOGY, 9, 11 pages. doi:10.3389/fphar.2018.00365.
  • 4. Zhou, J., Chooi, J. -Y., Ching, Y. Q., Quah, J. Y., Toh, S. H. -M., Ng, Y., . . . Chng, W. -J. (2018). NF-kappa B promotes the stem-like properties of leukemia cells by activation of LIN28B. WORLD JOURNAL OF STEM CELLS, 10(4), 34-42. doi:10.4252/wjsc.v10.i4.34.
  • 5. Zhou, J., Toh, S. H. -M., Chan, Z. -L., Quah, J. Y., Chooi, J. -Y., Tan, T. Z., . . . Chng, W. -J. (2018). A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/beta-catenin pathways for treatment of AML with high PRL-3 phosphatase. JOURNAL OF HEMATOLOGY & ONCOLOGY, 11, 12 pages. doi:10.1186/s13045-018-0581-9.